MicroTech Medical Hangzhou Co Ltd
HKEX:2235
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
MicroTech Medical Hangzhou Co Ltd
Accrued Liabilities
MicroTech Medical Hangzhou Co Ltd
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
|
Accrued Liabilities
¥24.6m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Accrued Liabilities
¥197.2m
|
CAGR 3-Years
26%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Accrued Liabilities
¥222.2m
|
CAGR 3-Years
8%
|
CAGR 5-Years
14%
|
CAGR 10-Years
17%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Accrued Liabilities
¥2.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Accrued Liabilities
¥56.6m
|
CAGR 3-Years
21%
|
CAGR 5-Years
15%
|
CAGR 10-Years
12%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Accrued Liabilities
¥922.4m
|
CAGR 3-Years
17%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
MicroTech Medical Hangzhou Co Ltd
Glance View
MicroTech Medical (Hangzhou) Co., Ltd. engages in the research, development, manufacture, and sale of diabetes management medical devices. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-10-19. The firm's products such as applicator insulin pump system (Equil), blood glucose monitoring system and continuous blood glucose monitoring system (AiDEX G7) have been commercialized. The firm's products, such as artificial pancreas, are in the process of research and development. The firm's products are sold to overseas markets such as the United States and the European Union.
See Also
What is MicroTech Medical Hangzhou Co Ltd's Accrued Liabilities?
Accrued Liabilities
24.6m
CNY
Based on the financial report for Dec 31, 2025, MicroTech Medical Hangzhou Co Ltd's Accrued Liabilities amounts to 24.6m CNY.
What is MicroTech Medical Hangzhou Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
15%
Over the last year, the Accrued Liabilities growth was -33%. The average annual Accrued Liabilities growth rates for MicroTech Medical Hangzhou Co Ltd have been -15% over the past three years , 15% over the past five years .
